Activation of plasminogen into plasmin at the surface of endothelial microparticles: A mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro

Blood

Volumn 110, Issue 7, 2007, Pages 2432-2439

  Lacroix, Romaric ^a   Sabatier, Florence ^a   Mialhe, Agnès ^a   Basire, Agnès ^a   Pannell, Ralph ^b   Borghi, Hélène ^c   Robert, Stephane ^a   Lamy, Edouard ^a   Plawinski, Laurent ^d   Camoin Jau, Laurence ^a   Gurewich, Victor ^b   Angles Cano, Eduardo ^d   Dignat George, Françoise ^a  

^a INSERM   (France)

^b HARVARD MEDICAL SCHOOL   (United States)

^c AIX MARSEILLE UNIVERSITY   (France)

^d UNIVERSITÉ DE CAEN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; CARBOXYPEPTIDASE B; PLASMIN; PLASMINOGEN; TUMOR NECROSIS FACTOR ALPHA; UROKINASE; UROKINASE RECEPTOR;

ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; STEM CELL;

CELL LINE; ENDOTHELIAL CELLS; ENZYME ACTIVATION; FIBRINOLYSIN; HUMANS; INTRACELLULAR MEMBRANES; NEOVASCULARIZATION, PHYSIOLOGIC; PLASMINOGEN; PROTEIN BINDING; RECEPTORS, CELL SURFACE; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; STEM CELLS; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 34948812510     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-02-069997     Document Type: Article

References (42)

1. Freyssinet JM. Cellular microparticles: what are they bad or good for? J Thromb Haemost. 2003;1:1655-1662.
2. Piccin A, Murphy WG, Smith OP. Circulating microparticles: pathophysiology and clinical implications. Blood Rev. 2007;21:157-171.
3. Morel O, Toti F, Hugel B, et al. Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol. 2006;26:2594-2604.
4. Combes V, Simon AC, Grau GE, et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest. 1999;104:93-102.
5. Bernal-Mizrachi L, Jy W, Jimenez JJ, et al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J. 2003;145:962-970.
6. Faure V, Dou L, Sabatier F, et al. Elevation of circulating endothelial microparticles in patients with chronic renal failure. J Thromb Haemost. 2006;4:566-573.
7. Sabatier F, Darmon P, Hugel B, et al. Type 1 and 2 diabetic patients display different patterns of cellular microparticles. Diabetes. 2002;51:2840-2845.
8. Dignat-George F, Camoin-Jau L, Sabatier F, et al. Endothelial microparticles: a potential contribution to the thrombotic complications of antiphospholipid syndrome. Thromb Haemost. 2004;91:667-673.
9. Jimenez JJ, Jy W, Mauro LM, Horstmann LL, Soderland C, Ahn YS. Endothelial microparticles released in Thrombotic thromcytopenic purpura express von Willebrand factor and markers of endothelial activation. Br J Haematol. 2003;123:896-902.
10. Shet AS, Aras O, Gupta K, et al. Sickle blood contains tissue factor - positive microparticles derived from endothelial cells and monocytes. Blood. 2003;102:2678-2683.
11. Giesen PL, Rauch U, Bohrmann B, et al. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U SA. 1999;96:2311-2315.
12. Muller I, Klocke A, Alex M, et al. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets. FASEB J. 2003;17:476-478.
13. Biro E, Sturk-Maquelin KN, Vogel GMT, et al. Human-cell derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J Thromb Haemost. 2003;197:1585-1598.
14. Steppich B, Mattisek C, Sobczyk D, Kastrati A, Schomig A, Ott I. Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction. Thromb Haemost. 2005;93:35-39.
15. Perez-Casal M, Downey C, Fukudome K, Marx G, Toh CH. Activated protein C induces the release of microparticle-associated endothelial protein C receptor. Blood. 2005;105:1515-1522.
16. Lijnen HR. Elements of the fibrinolytic system. Ann N Y Acad Sci. 2001;936:226-236.
17. Tkachuk V, Stepanova V, Little PJ, Bobik A. Regulation and role of urokinase plasminogene activator in vascular remodelling. Clin Exp Pharmacol Physiol. 1996;23:759-765.
18. Lijnen HR. Plasmin and matrix metalloproteinases in vascular remodeling. Thromb Haemost. 2001;86:324-33.
19. Tarui T, Majumdar M, Miles LA, Ruf W, Takada Y. Plasmin-induced migration of endothelial cells: a potential target for the anti-angiogenic action of angiostatin. J Biol Chem. 2002;277:33564-33570.
20. Rossignol P, Ho-Tin-Noe B, Vranckx R, et al. Protease nexin-1 inhibits plasminogen activation-induced apoptosis of adherent cells. J Biol Chem. 2004;279:10346-10356.
21. Rossignol P, Luttun A, Martin-Ventura JL, et al. Plasminogen activation: a mediator of vascular smooth muscle cell apoptosis in atherosclerotic plaques. J Thromb Haemost. 2006;4:664-670.
22. Fleury V, Angles-Cano E. Characterization of the binding of plasminogen to fibrin surfaces: the role of carboxy-terminal lysines. Biochemistry. 1991;30:7630-7638.
23. Ades EW, Candal FJ, Swerlick RA, et al. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol. 1992;99:683-690.
24. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria. J Clin Invest. 1973;52:2745-2756.
25. Bouis D, Hospers GA, Meijer C, Molema G, Mulder NH. Endothelium in vitro: a review of human vascular endothelial cell lines for blood vessel - related research. Angiogenesis. 2001;4:91-102.
26. Sabatier F, Roux V, Anfosso F, Camoin L, Sampol J, Dignat-George F. Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor - dependent procoagulant activity. Blood. 2002;991:3962-3970.
27. Plow EF, Herren T, Redlitz A, Miles LA, Hoover-Plow JL. The cell biology of the plasminogen system. FASEB J. 1995;9:939-945.
28. Ellis V. Plasminogen activation at the cell surface. Curr Top Dev Biol. 2003;54:263-312.
29. Farina AR, Tiberio A, Tacconelli A, Cappabianca L, Gulino A, Mackay AR. Identification of plasminogen in Matrigel and its activation by reconstitution of this basement membrane extract. Biotechniques. 1996;21:904-909.
30. Brodsky SV, Malinowski K, Golightly M, et al. Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potential. Circulation. 2002;106:2372-2378.
31. Lopez-Alemany R, Longstaff C, Hawley S, et al. Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against alpha-Enolase. Am J Hematol. 2003;72:234-242.
32. Lamanuzzi LB, Mtairag el M, Pepe G, Angles-Cano E. Neutrophils stimulated by apolipoprotein( a) generate fragments that are stronger inhibitors of plasmin formation than apo(a). Thromb Haemost. 2004;92:1066-1075.
33. Angelucci A, D'Ascenzo S, Festuccia C, et al. Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines. Clin Exp Metastasis. 2000;18:163-170.
34. Ellis V, Murphy G. Cellular strategies for proteolytic targeting during migration and invasion. FEBS Lett. 2001;506:1-5.
35. Basire A, Sabatier F, Ravet S, et al. High urokinase expression contributes to the angiogenic properties of endothelial cells derived from circulating progenitors. Thromb Haemost. 2006;95:678-688.
36. Hristov M, Weber C. Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. J Cell Mol Med. 2004;8:498-508.
37. Taraboletti G, D'Ascenzo S, Borsotti P, et al. Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle - associated components by endothelial cells. Am J Pathol. 2002;160:673-680.
38. Meilhac O, Ho-Tin-Noé B, Houard X, Philippe M, Michel JB, Angles-Cano E. Pericellular plasmin induces smooth muscle cell anoíkis. FASEB J. 2003;17:1301-1303.
39. Davis J, Wagner MR, Zhang W, Xu F, Van Nostrand WE. Amyloid beta-protein stimulates the expression of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) in human cerebrovascular smooth muscle cells. J Biol Chem. 2003;278:19054-19061.
40. Mezentsev A, Merks RM, O'Riordan E, et al. Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress. Am J Physiol Heart Circ Physiol. 2005;289:H1106-H1114.
41. Bompais H, Chagraoui J, Canron X, et al. Human endothelial cells derived from circulating progenitors display specific functional properties compared with mature vessel wall endothelial cells. Blood. 2004;103:2577-2584.
42. Simak J, Gelderman MP, Yu H, Wright V, Baird AE. Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome. J Thromb Haemost. 2006;4:1296-1302.